EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.4.24.77 | Wiskott-Aldrich Syndrome |
21697900 |
The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function. |
unassigned |
0 |
| 3.4.24.77 | Wiskott-Aldrich Syndrome |
22039045 |
Enterolobium contortisiliquum trypsin inhibitor (EcTI), a plant proteinase inhibitor, decreases in vitro cell adhesion and invasion by inhibition of Src protein-focal adhesion kinase (FAK) signaling pathways. |
causal interaction
ongoing research
therapeutic application
unassigned |
3
3
1
0 |
| 3.4.24.77 | Wound Infection |
2478526 |
Inhibitory effect of alpha 2-macroglobulin on Vibrio vulnificus protease. |
causal interaction
unassigned |
2
0 |
| 3.4.24.77 | Wound Infection |
8789055 |
Actions of Vibrio vulnificus metalloprotease on human plasma proteinase-proteinase inhibitor systems: a comparative study of native protease with its derivative modified by polyethylene glycol. |
unassigned |
0 |
| 3.4.24.77 | Wound Infection |
9393733 |
Functional domains of a zinc metalloprotease from Vibrio vulnificus. |
unassigned |
0 |
| 3.4.24.77 | Wound Infection |
10816513 |
Metalloprotease is not essential for Vibrio vulnificus virulence in mice. |
causal interaction
unassigned |
4
0 |
| 3.4.24.77 | Wound Infection |
12628443 |
Histamine-releasing reaction induced by the N-terminal domain of Vibrio vulnificus metalloprotease. |
ongoing research
unassigned |
4
0 |
| 3.4.24.77 | Wound Infection |
14726228 |
High growing ability of Vibrio vulnificus biotype 1 is essential for production of a toxic metalloprotease causing systemic diseases in humans. |
causal interaction
unassigned |
3
0 |
| 3.4.24.77 | Wound Infection |
17644589 |
The N-terminal propeptide of Vibrio vulnificus extracellular metalloprotease is both an inhibitor of and a substrate for the enzyme. |
unassigned |
0 |
| 3.4.24.77 | Wound Infection |
26105518 |
Development of an insect metalloproteinase inhibitor drug carrier system for application in chronic wound infections. |
therapeutic application
unassigned |
4
0 |
